NEW YORK, Oct. 7 (GenomeWeb News) - Aclara BioSciences said today that it has been granted its 96th patent covering its eTag assay technology.
The latest patent (US No. 6,627,400, titled "Multiplexed Measurement of Membrane Protein Populations") covers the use of the technology for the measurement of populations of proteins such as receptors on cell surfaces.
"The invention is for any method of measuring cell surface proteins like receptors that employs releasable reporter molecules that are separated from an assay mixture," said Sharat Singh, senior vice president of eTag Technology at Aclara.
According to Thomas Klopack, CEO of Aclara, the company is seeing "a high level of interest from potential pharmaceutical and biotech customers" in assays directed to cell surface proteins as biomarkers.